HOXA9 and chronic myelogenous leukemia, BCR-ABL1 positive: In conclusion, this study demonstrated that low expression levels of the tumor suppressor, miR-196b, were associated with up-regulation of the oncogenes BCR-ABL1 and HOXA9, ultimately leading to the development of CML.